Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis.

Autor:	Persichino JG; Harbor-UCLA Medical Center, Division of Infectious Diseases, 1000 West Carson Street, Torrance, CA 90509, USA., Can AD; Harbor-UCLA Medical Center, Division of Respiratory & Critical Care Physiology & Medicine, 1000 West Carson Street, Torrance, CA 90509, USA., Van TT; Harbor-UCLA Medical Center, Department of Pathology, 1000 West Carson Street, Torrance, CA 90509, USA., Matthews MN; Harbor-UCLA Medical Center, Department of Pathology, 1000 West Carson Street, Torrance, CA 90509, USA., Filler SG; Harbor-UCLA Medical Center, Division of Infectious Diseases, 1000 West Carson Street, Torrance, CA 90509, USA.
Jazyk:	angličtina
Zdroj:	Medical mycology case reports [Med Mycol Case Rep] 2018 Mar 06; Vol. 21, pp. 12-15. Date of Electronic Publication: 2018 Mar 06 (Print Publication: 2018).
DOI:	10.1016/j.mmcr.2018.03.004
Abstrakt:	Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in non-cirrhotic patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. The prevalence of each infection is low among patients with hepatic cirrhosis. We report the first likely case of combined invasive pulmonary mucormycosis and aspergillosis in a male with decompensated hepatic cirrhosis. This report also highlights the first non-diabetic case of invasive pulmonary mucormycosis with decompensated hepatic cirrhosis.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu